Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 18 March 2024)
| Date | 18 March 2024 |
|---|---|
| Court | CFI |
| Division | Munich (DE) Central Division - Section |
| Type of action | Revocation Action |
| Case number(s) | UPC_CFI_80/2023 |
| Registry reference | ACT_465342/2023 · ORD_598256/2023 · UPC_CFI_80/2023 |
| Parties | ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE v. Osaka University, Healios K.K |
Official decision (PDF) · UPC registry entry
Case timeline
- 11 October 2023 : Astellas Institute for Regenerative Medicine v Healios K.K (CFI, UPC_CFI_80/2023, 11 October 2023) ORD_579545/2023 · UPC_CFI_80/2023
- 17 November 2023 : Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 17 November 2023) ORD_584830/2023 · UPC_CFI_80/2023
- 20 November 2023 : Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 20 November 2023) ORD_579547/2023 · UPC_CFI_80/2023
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By an order of 18 March 2024 following the interim conference (UPC_CFI_80/2023, ACT_465342/2023, order no. 598256), the judge-rapporteur of panel 1 of the Munich Central Division (A. Kupecz), in the revocation action on EP 3 056 564 brought by Astellas Institute for Regenerative Medicine against Healios K.K and Osaka University, admitted document D21, set the value of the proceedings at EUR 4,000,000 for the scale of ceilings on recoverable costs and confirmed the oral hearing for 26 June 2024.
Question
How does the judge-rapporteur deal, at the close of the interim conference, with the admission of a late document, the value of the proceedings and the timetable for costs submissions?
Decision
Document D21 was admitted, on condition that the Defendant may file a succinct reply, possibly with a short reply expert report, by 11 April 2024, strictly limited to the points raised. After discussion with the parties, the value of the proceedings was set at EUR 4,000,000 (Rule 104(j) in connection with Rule 152.3 RoP). The judge-rapporteur noted that the scale sets a ceiling on recoverable costs rather than an amount owed, that under Art. 69 UPCA reasonable and proportionate costs are borne by the unsuccessful party, and that the Court will in principle respect an agreement between the parties on their amount. Costs exhibits may be filed until 11 June 2024, with an update by noon CET on 24 June 2024.
Key points for practice
- Practical point: the interim conference is where the value of the proceedings and the costs timetable are fixed, parties should document their costs before the hearing and consider agreeing on the amount.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 69
- Rules of Procedure
- Rules 9, 28, 104(j), 105.1, 105.5, 106, 108, 152.3 and 333
Related decisions
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: Revocation action.
Publications by Matthieu Dhenne: G 1/25, Take Three: Anything You Leave in the Description May Be Used Against You (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- claimantASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE10 decisions in the corpusFollow this party
- defendantHealios K.K5 decisions in the corpusFollow this party
- defendantOsaka University9 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
- 11 October 2023 Astellas Institute for Regenerative Medicine v Healios K.K (CFI, UPC_CFI_80/2023, 11 October 2023) Revocation Action · UPC_CFI_80/2023
Le mémoire en défense à l'action en nullité est réputé signifié à la demanderesse le 29 septembre 2023, le délai de réponse à la demande de sursis sera fixé par une ordonnance distincte.
- 17 November 2023 Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 17 November 2023) Revocation Action · UPC_CFI_80/2023
L'annexe confidentielle n'est accessible qu'aux représentants des défenderesses et à trois personnes physiques désignées, dont un conseil externe. Elle est soustraite à l'accès des tiers et l'appel est autorisé.
- 20 November 2023 Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 20 November 2023) Revocation Action · UPC_CFI_80/2023
Le sursis à statuer sur l'action en nullité est refusé : une décision de la division d'opposition proche mais susceptible de recours n'emporte pas, à ce stade, une décision rapide justifiant la suspension, l'appel est autorisé.
- 18 March 2024 Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 18 March 2024) Revocation Action · UPC_CFI_80/2023
What the record states
- Nature of the act
- Revocation Action
- Outcome (Dhenne Avocats summary)
- Le document D21 est admis sous réserve d'une réponse de la défenderesse avant le 11 avril 2024, la valeur du litige est fixée à 4 000 000 euros et l'audience confirmée au 26 juin 2024.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 056 564mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 18 March 2024) cited in this record
- Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 20 November 2023) cited in this record
- Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 17 November 2023) cited in this record
- Astellas Institute for Regenerative Medicine v Healios K.K (CFI, UPC_CFI_80/2023, 11 October 2023) cited in this record
- Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, ORD_465342/2023, 16 June 2023) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 056 564 | Mentioned in the analysis (role not qualified) Also mentioned in 6 other decision(s): Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 23 Ju · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 20 No · Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 17 N · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, UPC_C · Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, ORD_ · Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, ORD_ | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.